ACTG2 | Actin, gamma 2, smooth muscle, enteric | Cytoskeleton related proteins
| | | | | Tissue enhanced |
AL031663.2 | CDNA FLJ26875 fis, clone PRS08969; Uncharacterized protein | | | | | | Tissue enhanced |
AP001579.1 | Uncharacterized protein | | | | | | Tissue enhanced |
ASIC2 | Acid-sensing (proton-gated) ion channel 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ASPN | Asporin | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins
| | | | | Tissue enhanced |
BNC2 | Basonuclin 2 | Transcription factors
| | | | | Tissue enhanced |
C3orf70 | Chromosome 3 open reading frame 70 | Cancer-related genes
| | | | | Tissue enhanced |
CHURC1-FNTB | CHURC1-FNTB readthrough | | | | | | Tissue enhanced |
CILP | Cartilage intermediate layer protein, nucleotide pyrophosphohydrolase | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CNN1 | Calponin 1, basic, smooth muscle | Cancer-related genes Cytoskeleton related proteins
| | | | | Tissue enhanced |
COL4A6 | Collagen, type IV, alpha 6 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
COL6A3 | Collagen, type VI, alpha 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
FAM83D | Family with sequence similarity 83, member D | | | | | | Tissue enhanced |
FBXL22 | F-box and leucine-rich repeat protein 22 | | | | | | Tissue enhanced |
GAL | Galanin/GMAP prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GAL3ST3 | Galactose-3-O-sulfotransferase 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
GALR2 | Galanin receptor 2 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GJC1 | Gap junction protein, gamma 1, 45kDa | Predicted membrane proteins
| | | | | Tissue enhanced |
GLRA4 | Glycine receptor, alpha 4 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GPR161 | G protein-coupled receptor 161 | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GREM1 | Gremlin 1, DAN family BMP antagonist | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
GRM7 | Glutamate receptor, metabotropic 7 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GUCY1A2 | Guanylate cyclase 1, soluble, alpha 2 | Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
HAND1 | Heart and neural crest derivatives expressed 1 | Transcription factors
| | | | | Tissue enhanced |
HOXA10 | Homeobox A10 | Transcription factors
| | | | | Tissue enhanced |
HOXA11 | Homeobox A11 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
HOXC8 | Homeobox C8 | Transcription factors
| | | | | Tissue enhanced |
HOXD10 | Homeobox D10 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
KCNE4 | Potassium voltage-gated channel, Isk-related family, member 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
KCNMA1 | Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNMB1 | Potassium large conductance calcium-activated channel, subfamily M, beta member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
KLHL13 | Kelch-like family member 13 | | | | | | Tissue enhanced |
LCN6 | Lipocalin 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
LEFTY2 | Left-right determination factor 2 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
LINGO2 | Leucine rich repeat and Ig domain containing 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
MFAP5 | Microfibrillar associated protein 5 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MOXD1 | Monooxygenase, DBH-like 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NPAS4 | Neuronal PAS domain protein 4 | Transcription factors
| | | | | Tissue enhanced |
NRXN3 | Neurexin 3 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
P4HA3 | Prolyl 4-hydroxylase, alpha polypeptide III | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
PCDH20 | Protocadherin 20 | Predicted membrane proteins
| | | | | Tissue enhanced |
PI15 | Peptidase inhibitor 15 | Predicted secreted proteins
| | | | | Tissue enhanced |
PTGES3L-AARSD1 | PTGES3L-AARSD1 readthrough | | | | | | Tissue enhanced |
RSPO3 | R-spondin 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
SEL1L2 | Sel-1 suppressor of lin-12-like 2 (C. elegans) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SULF1 | Sulfatase 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
TACR2 | Tachykinin receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |